Jared Holz
Healthcare market strategist at Mizuho Securities, offering insights into the biotech market's current state.
Best podcasts with Jared Holz
Ranked by the Snipd community
9 snips
Feb 20, 2025 • 41min
342: FDA cuts, zombie biotechs, and too much weight loss?
Jared Holz, a healthcare market strategist at Mizuho Securities, shares insights into the biotech landscape's challenges and prospects. He discusses the impact of recent FDA cuts on drug manufacturing, raising concerns about staffing shortages. The conversation also dives into the disconnect between pharmaceutical goals for weight loss and patient experiences, plus the rise of 'zombie' biotech companies. Holz emphasizes the importance of accountability in a stagnating market and highlights promising developments in gene therapy despite industry hurdles.
Sep 19, 2024 • 35min
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Jared Holz, a biotech stock and startup analyst, dives into the implications of the Federal Reserve's interest rate cuts on the biotech industry. He discusses the innovative use of cannabinoids in obesity treatments and the caution required in drug development. The conversation also highlights the prestigious Lasker Awards for significant contributions to GLP-1 hormone research. Additionally, Holz examines the challenges within the biotech market, including investor sentiment and competition in the obesity sector.
